Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Zandra Lopez, M.D.
Internal Medicine · HOMESTEAD, FL · NPI 1487815080
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1109 | 301 |
| Losartan Potassium | Losartan Potassium | 839 | 216 |
| Famotidine | Famotidine | 566 | 172 |
| Gabapentin | Gabapentin | 557 | 127 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 543 | 146 |
| Levothyroxine Sodium | Levothyroxine Sodium | 502 | 124 |
| Hydrochlorothiazide | Hydrochlorothiazide | 473 | 132 |
| Amlodipine Besylate | Amlodipine Besylate | 462 | 131 |
| Lisinopril | Lisinopril | 433 | 107 |
| Metformin Hcl | Metformin Hcl | 399 | 100 |
| Omeprazole | Omeprazole | 389 | 113 |
| Fluticasone Propionate | Fluticasone Propionate | 353 | 117 |
| Xarelto | Rivaroxaban | 347 | 59 |
| Simvastatin | Simvastatin | 341 | 79 |
| Metoprolol Tartrate | Metoprolol Tartrate | 318 | 76 |
| Metoprolol Succinate | Metoprolol Succinate | 291 | 78 |
| Alendronate Sodium | Alendronate Sodium | 265 | 98 |
| Tamsulosin Hcl | Tamsulosin Hcl | 262 | 70 |
| Furosemide | Furosemide | 229 | 73 |
| Montelukast Sodium | Montelukast Sodium | 193 | 66 |
| Pantoprazole Sodium | Pantoprazole Sodium | 190 | 60 |
| Clopidogrel | Clopidogrel Bisulfate | 184 | 50 |
| Donepezil Hcl | Donepezil Hcl | 176 | 46 |
| Sildenafil Citrate | Sildenafil Citrate | 171 | 28 |
| Carvedilol | Carvedilol | 157 | 40 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 155 | 48 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 145 | 73 |
| Escitalopram Oxalate | Escitalopram Oxalate | 139 | 43 |
| Trazodone Hcl | Trazodone Hcl | 135 | 44 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 132 | 84 |
| Eliquis | Apixaban | 131 | 29 |
| Allopurinol | Allopurinol | 128 | 29 |
| Glipizide Er | Glipizide | 116 | 39 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 116 | 26 |
| Alogliptin | Alogliptin Benzoate | 113 | 25 |
| Memantine Hcl | Memantine Hcl | 113 | 40 |
| Hydralazine Hcl | Hydralazine Hcl | 112 | 30 |
| Atenolol | Atenolol | 102 | 27 |
| Finasteride | Finasteride | 99 | 26 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 95 | 20 |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 89 | 89 |
| Dutasteride | Dutasteride | 88 | 29 |
| Metformin Hcl Er | Metformin Hcl | 86 | 24 |
| Folic Acid | Folic Acid | 84 | 35 |
| Chlorthalidone | Chlorthalidone | 82 | 22 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 80 | 20 |
| Spironolactone | Spironolactone | 78 | 16 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 76 | 30 |
| Irbesartan | Irbesartan | 75 | 18 |
| Bumetanide | Bumetanide | 73 | 20 |
| Gemfibrozil | Gemfibrozil | 73 | 18 |
| Fenofibrate | Fenofibrate | 71 | 20 |
| Nifedipine Er | Nifedipine | 67 | 17 |
| Pioglitazone Hcl | Pioglitazone Hcl | 65 | 14 |
| Benzonatate | Benzonatate | 62 | 44 |
| Solifenacin Succinate | Solifenacin Succinate | 62 | 16 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 61 | 17 |
| Dapagliflozin | Dapagliflozin Propanediol | 58 | 19 |
| Mirtazapine | Mirtazapine | 58 | 21 |
| Glipizide | Glipizide | 57 | 16 |
| Lactulose | Lactulose | 57 | 12 |
| Myrbetriq | Mirabegron | 57 | suppressed |
| Hydrocortisone | Hydrocortisone | 56 | 24 |
| Meloxicam | Meloxicam | 56 | 41 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 56 | 20 |
| Sertraline Hcl | Sertraline Hcl | 55 | 22 |
| Diclofenac Sodium | Diclofenac Sodium | 54 | 35 |
| Buspirone Hcl | Buspirone Hcl | 52 | 19 |
| Entresto | Sacubitril/Valsartan | 50 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 48 | 13 |
| Mupirocin | Mupirocin | 45 | 28 |
| Doxazosin Mesylate | Doxazosin Mesylate | 44 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 44 | 13 |
| Azelastine Hcl | Azelastine Hcl | 43 | 23 |
| Ibandronate Sodium | Ibandronate Sodium | 40 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 40 | 11 |
| Ibuprofen | Ibuprofen | 39 | 25 |
| Warfarin Sodium | Warfarin Sodium | 38 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 36 | 34 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 35 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 32 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 31 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 29 | suppressed |
| Ketoconazole | Ketoconazole | 29 | 16 |
| Tizanidine Hcl | Tizanidine Hcl | 29 | 27 |
| Estradiol | Estradiol | 28 | 11 |
| Lansoprazole | Lansoprazole | 28 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 28 | suppressed |
| Brilinta | Ticagrelor | 27 | suppressed |
| Naproxen | Naproxen | 26 | suppressed |
| Nyamyc | Nystatin | 26 | suppressed |
| Potassium Chloride | Potassium Chloride | 26 | suppressed |
| Celecoxib | Celecoxib | 23 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 23 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 23 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 23 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 23 | suppressed |
| Sucralfate | Sucralfate | 22 | suppressed |
| Trijardy Xr | Empaglifloz/Linaglip/Metformin | 22 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 21 | suppressed |
| Glimepiride | Glimepiride | 21 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 21 | suppressed |
| Insulin Glargine Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 20 | suppressed |
| Jardiance | Empagliflozin | 20 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 20 | suppressed |
| Synthroid | Levothyroxine Sodium | 20 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 19 | suppressed |
| Lovastatin | Lovastatin | 19 | suppressed |
| Pradaxa | Dabigatran Etexilate Mesylate | 19 | suppressed |
| Ranolazine Er | Ranolazine | 19 | suppressed |
| Sotalol | Sotalol Hcl | 19 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 19 | suppressed |
| Tradjenta | Linagliptin | 19 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 18 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 18 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 18 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 17 | suppressed |
| Levoxyl | Levothyroxine Sodium | 17 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 16 | suppressed |
| Pregabalin | Pregabalin | 16 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 16 | suppressed |
| Comfort Ez Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 15 | suppressed |
| Dapagliflozin-Metformin Er | Dapaglifloz Propaned/Metformin | 15 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 15 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 15 | suppressed |
| Ezetimibe | Ezetimibe | 14 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 14 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 14 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 14 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 14 | suppressed |
| Ramipril | Ramipril | 14 | suppressed |
| Valsartan | Valsartan | 14 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Loperamide | Loperamide Hcl | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 12 | suppressed |
| Ciclopirox | Ciclopirox | 12 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 12 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 12 | 11 |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Alogliptin-Metformin | Alogliptin Benz/Metformin Hcl | 11 | suppressed |
| Cilostazol | Cilostazol | 11 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 11 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error